New York City Congestion Pricing Program
Sector: Road • Location: New York, United States
Source: The Guardian
The Trump administration has ordered New York City to end its congestion pricing program, which imposes fees on drivers entering Manhattan below 60th Street during peak hours. The decision was communicated by the Federal Highway Administration, which stated that toll collection must cease by March 21, 2025.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | cancelled |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | The Trump administration has ordered New York City to end its congestion pricing program, which imposes fees on drivers entering Manhattan below 60th Street during peak hours. The decision was communicated by the Federal Highway Administration, which stated that toll collection must cease by March 21, 2025. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |
More Road projects in United States
- Engineering, Procurement, and Construction of Third Bosphorus Bridge
- Morphotek’s New Biologics Production Facility
- LabCentral 238, Cambridge, Massachusetts, USA
- Kite Pharma’s Viral Vector Manufacturing Facility, California, US
- Eli Lilly’s Parenteral Product and Device Manufacturing Facility, Concord, North Carolina
- Amgen’s Drug Substance Manufacturing Plant, Wake County, North Carolina
- Vertex Pharmaceuticals’ Boston Campus
- Roche Diagnostics PCR Diagnostic Kits
